Finerenone

New guidelines and consensus this year

1. Kidney disease and heart failure: recent advances and current challenges: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
   Kidney Int2026 Jun
2. Ibero-American position statement on therapeutic recommendations for the preventive management of cardiovascular complications in latin-American patients with type 2 diabetes mellitus: consensus of the prevention council of the inter-American society of cardiology (SIAC-PREVENT)
   Diabetol Metab Syndr2026 Apr 12
3. Kidney Disease and Heart Failure: Recent Advances and Current Challenges: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
   JACC Heart Fail2026 Apr
4. [SEMERGEN position paper on chronic kidney disease]
   Semergen2026 Apr
5. Clinical Approach to Heart Failure with Preserved Ejection Fraction (HFpEF) in South Asia: An Expert Consensus Statement
   Curr Cardiol Rev2026

1. Early mineralocorticoid receptor antagonism for end-organ protection in hypertension: Implications for disparities and rethinking the timing paradigm
   Dialogues Health2026 DecPMID 42733634Review
2. Efficacy and safety of finerenone in adults with IgA nephropathy: a 12-month real-world study
   Ren Fail2026 DecPMID 42634326
3. Finerenone attenuates chronic fibrotic remodeling during the AKI-CKD transition in an ischemia-reperfusion-induced acute kidney injury mouse model
   Ren Fail2026 DecPMID 42414246
4. Bibliometric analysis of SGLT2 inhibitor treatment for diabetic kidney disease
   Ren Fail2026 DecPMID 42167310Review
5. Finerenone in IgA nephropathy: real-world 12-month propensity-matched cohort demonstrating proteinuria reduction, eGFR preservation, and safety profile
   Ren Fail2026 DecPMID 42002725
6. Finerenone attenuates myocardial fibrosis in myocardial infarction complicated by chronic kidney disease: an integrated study combining network pharmacology, molecular simulations, and in vivo experiments
   Eur J Pharmacol2026 Nov 10PMID 42762910
7. Finerenone improves vascular function in association with reduced aortic sodium content in aldosterone/salt-loaded uninephrectomized rats
   J Pharmacol Sci2026 NovPMID 42810778
8. Finerenone for IgA Nephropathy After Renin-Angiotensin System Inhibitors Discontinuation: A Multicentre Retrospective Cohort Study
   Diabetes Obes Metab2026 NovPMID 42605541
9. From pathobiology to prescribing in obesity-driven HFpEF: A systematic review and practical therapeutic framework
   Curr Probl Cardiol2026 NovPMID 42586458Systematic review
10. Finerenone ameliorated ventricular remodeling post myocardial infarction in rats by reducing NF-KB pathway-mediated pyroptosis
    Eur J Pharmacol2026 Oct 15PMID 42628621